Coagulation abnormalities in patients with COVID-19 on venovenous ECLS increased risk for technical complications and support times but had no impact on survival.

Karla LehleAlois PhilippMaik FoltanFrank SchettlerMarkus RitzkaThomas MüllerMatthias Lubnow

Published in: Artificial organs (2022)

The survival of ECLS patients with COVID-19 was independent of the requirement for system exchange due to technical-induced coagulation disorders. Close monitoring for circuit clotting is mandatory in COVID-19 patients and is one prerequisite for successful organ support in these difficult patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
extracorporeal membrane oxygenation
prognostic factors
peritoneal dialysis
free survival
risk factors
patient reported